Immediate Impact

5 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Yasuo Oshima being referenced

EGFR–TKI-Associated Interstitial Pneumonitis in Nivolumab-Treated Patients With Non–Small Cell Lung Cancer
2018

Author Peers

Author Last Decade Papers Cites
Yasuo Oshima 155 157 115 280 250 47 1.0k
Faripour Forouhar 324 148 161 233 277 67 1.3k
Ender Terzıoğlu 354 192 94 126 99 50 1.2k
Xin Gao 237 89 59 151 177 52 962
Roy A. Axelsen 269 82 149 217 126 40 1.1k
Kateřina Kaňková 307 129 99 58 81 74 1.2k
Carlo Giansante 411 121 174 111 133 54 1.2k
Karen J. Klamerus 485 34 45 367 341 40 1.2k
Gülen Akyol 321 68 400 139 185 78 1.2k
H. Borberg 161 257 52 104 84 90 1.2k
Toshihiko Nagasawa 435 134 85 340 37 96 1.4k

All Works

Loading papers...

Rankless by CCL
2026